GlassScriptPhysician profile
Tameem M Souman
NPI 1831355817
$5,533.85
in general payments reported to CMS, 2019-2025
16 companies · $1,955 in 2025
The $1,955 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,074 · 2020: $40.40 · 2021: $176 · 2022: $171 · 2023: $47.38 · 2024: $70.05 · 2025: $1,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,385 · Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,385.00 |
| Food and Beverage | $687.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,234.41 | 2019-2025 | Indigo System |
| Canon Medical Systems USA, INC. | $655.97 | 2019 | |
| Becton, Dickinson and Company | $188.41 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $145.56 | 2019-2022 | |
| Medtronic, INC. | $48.84 | 2022-2023 | Concertotm |
| Incyte Corporation | $39.19 | 2022-2023 | Jakafi |
| Boston Scientific Corporation | $27.00 | 2019 | |
| Genentech USA, INC. | $26.81 | 2024 | Phesgo, Kadcyla, Perjeta |
| Ge Healthcare | $26.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.71 | 2020 | |
| Inari Medical, INC. | $24.01 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $23.94 | 2025 | Artix Mt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.58 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.23 | 2024 | Ninlaro |
| Astrazeneca Pharmaceuticals LP | $15.70 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tameem Souman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.